Image

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Join our study on new treatments for Crohn's and Ulcerative Colitis.

Recruiting
18-75 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is for adults with Crohn's Disease (CD) or Ulcerative Colitis (UC), which are diseases that cause redness and swelling in the digestive system. CD can make your belly hurt, cause diarrhea, tiredness, and weight loss, while UC affects the colon and rectum, causing bleeding and belly pain. The study aims to see if new treatments can help people with these diseases feel better. This includes two substudies that will test different combinations of drugs: *risankizumab* with either *trosunilimab* (ABBV-466) or *ABBV-701* (ABBV-7066). Participants will be randomly assigned to a treatment group and will have regular hospital or clinic visits to check the effect of the treatments through medical tests.

  • Study involves regular hospital visits and various tests.
  • Approximately 100 participants per treatment group at 400 global sites.
  • Higher treatment burden compared to standard care.
Print
Study details
    Crohn's Disease
    Ulcerative Colitis

NCT07697456

AbbVie

11 October 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.